The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Modifiable and non-modifiable risk factors for pancreatic cancer: A review
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
New Users of Metformin Are at Low Risk of Incident Cancer
Libby, G., Donnelly, L. A., Donnan, P. T., Alessi, D. R., Morris, A. D., & Evans, J. M. M. (2009) · Diabetes Care · doi:10.2337/dc08-2175 · Cited by 996
Molecular genetics of pancreatic intraepithelial neoplasia
Feldmann, G., Beaty, R., Hruban, R. H., & Maitra, A. (2007) · Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.1007/s00534-006-1166-5 · Cited by 269
Time to progression of pancreatic ductal adenocarcinoma from low-to-high tumour stages
Yu, J., Blackford, A. L., dal Molin, M., Wolfgang, C. L., & Goggins, M. (2015) · Gut · doi:10.1136/gutjnl-2014-308653 · Cited by 224
Klein, A. P., Lindström, S., Mendelsohn, J. B., Steplowski, E., Arslan, A. A., Bueno-de-Mesquita, H. B., Fuchs, C. S., Gallinger, S., Gross, M., Helzlsouer, K., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072311 · Cited by 148
Research works printed but not linked: 108
- Edwards, 2014, Annual Report to the Nation on the status of cancer, 1975–2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer, Cancer, 120, 1290, 10.1002/cncr.28509 · DOI · Paper page
- Ishikawa, 1980, Adenosquamous carcinoma of the pancreas, a clinicopathologic study and report of three cases, Cancer, 46, 1192, 10.1002/1097-0142(19800901)46:5<1192::AID-CNCR2820460519>3.0.CO;2-D · doi:10.1002/1097-0142(19800901)46:5<1192::aid-cncr2820460519>3.0.co;2-d
- Motojima, 1992, Immunohistochemical characteristics of adenosquamous carcinoma of the pancreas, J. Surg. Oncol, 49, 58, 10.1002/jso.2930490114 · doi:10.1002/jso.2930490114
- Bray, 2002, Estimation of cancer incidence and mortality in Europe in 1995, Eur. J. Cancer, 38, 99, 10.1016/S0959-8049(01)00350-1 · DOI · Paper page
- Lowenfels, 2002, Epidemiologic and etiologic factors of pancreatic cancer, Hematol. Oncol. Clin. North Am, 16, 1, 10.1016/S0889-8588(01)00003-X · DOI
- Lowenfels, 1997, Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis study group, J. Natl. Cancer Inst, 89, 442, 10.1093/jnci/89.6.442 · DOI · Paper page
- Wahi, 2009, Reproductive factors and risk of pancreatic cancer in women: a review of the literature, Ann. Epidemiol, 19, 103, 10.1016/j.annepidem.2008.11.003 · DOI
- Duell, 2009, Menstrual and reproductive factors and pancreatic cancer in the SEARCH program of the IARC, Cancer Causes Control, 20, 1757, 10.1007/s10552-009-9408-x · doi:10.1007/s10552-009-9408-x
- Chawla, 2015, Am. J. Gastroenterol, 110, S1, 10.1038/ajg.2015.269 · doi:10.1038/ajg.2015.269
- Arnold, 2009, Are racial disparities in pancreatic cancer explained by smoking and overweight/obesity?, Cancer Epidemiol. Biomarkers Prev, 18, 2397, 10.1158/1055-9965.EPI-09-0080 · DOI
- Silverman, 2002, Why do black Americans have a higher risk of pancreatic cancer than white Americans?, Epidemiology, 14, 46
- Blackford, 2009, Genetic mutations associated with cigarette smoking in pancreatic cancer, Cancer Res, 69, 3681, 10.1158/0008-5472.CAN-09-0015 · DOI · Paper page
- Pernick, 2003, Clinicopathologic analysis of pancreatic adenocarcinoma in African Americans and Caucasians, Pancreas, 26, 28, 10.1097/00006676-200301000-00006 · DOI
- Dong, 2000, Ki -ras point mutation in a p 53 expressions in human pancreatic cancer, a comparative study among Chinese, Japanese and Western patients, Cancer Epidemiol. Biomarkers Prev, 9, 279
- Song, 2000, Comparison of K-ras point mutation at codon 12 and p-21 expression in pancreatic cancer between Japanese and Chinese patients, J. Surg. Oncol, 75, 176, 10.1002/1096-9098(200011)75:3<176::AID-JSO5>3.0.CO;2-W · doi:10.1002/1096-9098(200011)75:3<176::aid-jso5>3.0.co;2-w
- Grunda, 2012, Differential expression of breast cancer-associated genes between stage- and age-matched tumor specimens from African- and Caucasian-American Women diagnosed with breast cancer, BMC Res. Notes, 5, 248, 10.1186/1756-0500-5-248 · DOI
- Longnecker, 2000, Racial difference in pancreatic cancer, comparison of survival and histologic types of pancreatic carcinoma in Asians, Blacks and Whites in the US, Pancreas, 21, 338, 10.1097/00006676-200011000-00003 · DOI
- Wolpin, 2009, ABO blood group and the risk of pancreatic cancer, J. Natl. Cancer Inst, 101, 424, 10.1093/jnci/djp020 · DOI · Paper page
- Wolpin, 2010, Pancreatic cancer risk and ABO blood group alleles: results from the pancreatic cancer cohort consortium, Cancer Res, 70, 1015, 10.1158/0008-5472.CAN-09-2993 · DOI · Paper page
- Amundadottir, 2009, Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer, Nat. Genet, 41, 986, 10.1038/ng.429 · DOI · Paper page
- Landi, 2009, Genetic predisposition and environmental risk factors to pancreatic cancer: a review of the literature, Mutat. Res, 681, 299, 10.1016/j.mrrev.2008.12.001 · DOI
- Bracci, 2012, Obesity and pancreatic cancer: overview of epidemiologic evidence and biologic mechanisms, Mol. Carcinog, 51, 53, 10.1002/mc.20778 · DOI · Paper page
- Stolzenberg-Solomon, 2001, Dietary and other methyl-group availability factors and pancreatic cancer risk in a cohort of male smokers, Am. J. Epidemiol, 153, 680, 10.1093/aje/153.7.680 · DOI
- Yeo, 2015, Demographics, epidemiology, and inheritance of pancreatic ductal adenocarcinoma, Semin. Oncol, 42, 8, 10.1053/j.seminoncol.2014.12.002 · DOI
- Petersen, 2010, A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33, Nat. Genet, 42, 224, 10.1038/ng.522 · DOI · Paper page
- Low, 2010, Genome-wide association study of pancreatic cancer in Japanese population, PLoS ONE, 5, e11824, 10.1371/journal.pone.0011824 · DOI
- Wu, 2012, Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations, Nat. Genet, 44, 62, 10.1038/ng.1020 · DOI · Paper page
- Raimondi, 2009, Epidemiology of pancreatic cancer: an overview, Nat. Rev. Gastroenterol. Hepatol, 6, 699, 10.1038/nrgastro.2009.177 · DOI · Paper page
- Raimondi, 2007, Early onset pancreatic cancer: evidence of a major role for smoking and genetic factors, Cancer Epidemiol. Biomarkers Prev, 16, 1894, 10.1158/1055-9965.EPI-07-0341 · DOI
- Jones, 2008, Core signaling pathways in human pancreatic cancers revealed by global genomic analyses, Science, 321, 1801, 10.1126/science.1164368 · DOI · Paper page
- Lowenfel, 1993, Pancreatitis and the risk of pancreatic cancer, N. Engl. J. Med, 328, 1433, 10.1056/NEJM199305203282001 · DOI · Paper page
- Fernandez, 1995, Pancreatitis and the risk of pancreatic cancer, Pancreas, 11, 185, 10.1097/00006676-199508000-00012 · DOI
- Bansal, 1995, Pancreatitis is a risk factor for pancreatic cancer, Gastroenterology, 109, 247, 10.1016/0016-5085(95)90291-0 · DOI · Paper page
- Moghaddam, 2006, The effect of modifiable risk factors on pancreatic cancer mortality in population of the Asia–Pacific Region, Cancer Epidemiol. Biomarkers Prev, 15, 2435, 10.1158/1055-9965.EPI-06-0368 · DOI
- Gold, 1985, Diet and other risk factors for cancer of the pancreas, Cancer, 55, 460, 10.1002/1097-0142(19850115)55:2<460::AID-CNCR2820550229>3.0.CO;2-V · DOI
- Mack, 1986, Pancreas cancer and smoking, beverage consumption and past medical history, J. Natl. Cancer Inst, 76, 49
- Bueno De Mesquita, 1992, Aspects of medical history andexocrine carcinoma of the pancreas: a population based case control study in the Netherlands, Int. J. Cancer, 52, 17, 10.1002/ijc.2910520105 · DOI
- Raimondi, 2010, Pancreatic cancer in chronic pancreatitis; aetiology, incidence, and early detection, Best Pract. Res. Clin. Gastroenterol, 24, 349, 10.1016/j.bpg.2010.02.007 · DOI · Paper page
- Midha, 2016, Genetically determined chronic pancreatitis but not alcoholic pancreatitis is a strong risk factor for pancreatic cancer, Pancreas, 10.1097/MPA.0000000000000684 · DOI
- Malka, 2002, Risk of pancreatic adenocarcinoma in chronic pancreatitis, Gut, 51, 849, 10.1136/gut.51.6.849 · DOI · Paper page
- Bright, 1833, Cases and observations connected with disease of the pancreas and duodenum, Med. Chir. Trans, 18, 1, 10.1177/09595287330180P102 · DOI
- Bell, 1957, Carcinoma of the pancreas, I, a Clinical and pathological study of 609 necropsied cases, II. The relation of carcinoma of the pancreas to diabetes mellitus, Am. J. Pathol, 33, 499
- Green, 1958, Diabetes Mellitus is associated with primary carcinoma of the pancreas, Diabetes, 7, 308, 10.2337/diab.7.4.308 · DOI
- Clark, 1961, Diabetes Mellitus and primary carcinoma of the pancreas, BMJ, 2, 1259, 10.1136/bmj.2.5262.1259 · doi:10.1136/bmj.2.5262.1259
- Everhart, 1995, Diabetes mellitus as a risk factor for PC. A meta-analysis, JAMA, 273, 1605, 10.1001/jama.1995.03520440059037 · DOI
- Huxley, 2005, Type II diabetes and pancreatic cancer- a meta-analysis of 36 studies, Br. J. Cancer, 92, 2076, 10.1038/sj.bjc.6602619 · DOI · Paper page
- Bosetti, 2014, Diabetes, antidiabetic medications, and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-Control Consortium, Ann. Oncol, 25, 2065, 10.1093/annonc/mdu276 · DOI · Paper page
- Bonelli, 2003, Exocrine pancreatic cancer, cigarette smoking, and diabetes mellitus: a case control studying northern Italy, Pancreas, 27, 143, 10.1097/00006676-200308000-00007 · DOI
- Chari, 2005, Probability of pancreatic cancer following diabetes: a population based study, Gastroenterology, 129, 504, 10.1016/j.gastro.2005.05.007 · doi:10.1016/j.gastro.2005.05.007 · Paper page
- Friedman, 1993, Risk factors for pancreatic cancer: an exploratory study, Int. J. Epidemiol, 22, 30, 10.1093/ije/22.1.30 · DOI
- Adami, 1991, Cancer risk in patients with diabetes mellitus, Cancer Causes Control, 2, 307, 10.1007/BF00051670 · DOI · Paper page
- Shibata, 1994, A prospective study of pancreatic cancer in the elderly, Int. J. Cancer, 58, 46, 10.1002/ijc.2910580109 · DOI · Paper page
- Munigala, 2015, Predictors for pancreatic cancer diagnosis following new-onset diabetes mellitus, Clin. Transl. Gastroenterol, 6, e118, 10.1038/ctg.2015.44 · DOI
- Jee, 2005, Fasting serum glucose level and cancer risk in Korean men and women, JAMA, 293, 194, 10.1001/jama.293.2.194 · DOI · Paper page
- Stocks, 2009, Blood glucose and risk of incident and fatal cancer in the metabolic syndrome and cancer project (me-can): analysis of six prospective cohorts, PLoS Med, 6, e1000201, 10.1371/journal.pmed.1000201 · DOI · Paper page
- Arslan, 2010, Anthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan), Arch. Intern. Med, 170, 791, 10.1001/archinternmed.2010.63 · DOI · Paper page
- Ding, 2000, Physiological concentrations of insulin augment pancreatic cancer cell proliferation and glucose utilization by activating MAP kinase, PI3 kinase and enhancing GLUT-1 expression, Pancreas, 21, 310, 10.1097/00006676-200010000-00014 · DOI
- Maisonneuve, 2010, Past medical history and pancreatic cancer risk: results from a multicenter case–control study, Ann. Epidemiol, 20, 92, 10.1016/j.annepidem.2009.11.010 · DOI
- Li, 2009, Anti-diabetic therapies affect risk of pancreatic cancer, Gastroenterology, 137, 482, 10.1053/j.gastro.2009.04.013 · DOI · Paper page
- Evans, 2005, Metformin and reduced risk of cancer of 25–37% in diabetic patients, BMJ, 330, 1304, 10.1136/bmj.38415.708634.F7 · DOI · Paper page
- Cui, 2012, Diabetes and pancreatic cancer, Endocr. Relat. Cancer, 19, F9, 10.1530/ERC-12-0105 · DOI · Paper page
- Egan, 2014, Pancreatic safety of incretin-based drugs–FDA and EMA assessment, N. Engl. J. Med, 370, 794, 10.1056/NEJMp1314078 · DOI · Paper page
- Dobbins, 2013, The association between obesity and cancer risk: a meta-analysis of observational studies from 1985 to 2011, ISRN Prev. Med, 2013, 10.5402/2013/680536 · DOI · Paper page
- Li, 2010, New strategies in pancreatic cancer: emerging epidemiological and therapeutic concepts, Clin. Cancer Res, 16, 4313, 10.1158/1078-0432.CCR-09-1942 · DOI
- Rebours, 2015, Obesity and fatty pancreatic infiltration are risk factors for pancreatic precancerous lesions(PanIN), Clin. Cancer Res, 21, 3522, 10.1158/1078-0432.CCR-14-2385 · DOI · Paper page
- Feakins, 2016, Obesity and metabolic syndrome: pathological effects on the gastrointestinal tract, Histopathology, 68, 630, 10.1111/his.12907 · DOI
- Zheng, 2009, Well-done meat intake, heterocyclic amine exposure, and Cancer risk, Nutr. Cancer, 61, 437, 10.1080/01635580802710741 · DOI · Paper page
- Schernhammer, 2005, Sugar-sweetened soft drink consumption and risk of pancreatic cancer in two prospective cohorts, Cancer Epidemiol. Biomarkers Prev, 14, 2098, 10.1158/1055-9965.EPI-05-0059 · DOI
- Larsson, 2006, Consumption of sugar and sugar-sweetened foods and the risk of pancreatic cancer in a prospective study, Am. J. Clin. Nutr, 84, 1171, 10.1093/ajcn/84.5.1171 · DOI · Paper page
- Mueller, 2010, Soft drink and juice consumption and risk of pancreatic cancer: the Singapore Chinese Health Study, Cancer Epidemiol. Biomarkers Prev, 19, 447, 10.1158/1055-9965.EPI-09-0862 · DOI
- Bae, 2009, Citrus fruit intake and pancreatic cancer risk: a quantitative systematic review, Pancreas, 38, 168, 10.1097/MPA.0b013e318188c497 · DOI
- Nöthlings, 2007, Flavonols and pancreatic cancer risk: the Multiethnic Cohort Study, Am. J. Epidemiol, 166, 924, 10.1093/aje/kwm172 · DOI · Paper page
- Stolzenberg-Solomon, 2001, Dietary and other methyl-group availability factors and pancreatic cancer risk in a cohort of male smokers, Am. J. Epidemiol, 153, 680, 10.1093/aje/153.7.680 · DOI
- Larsson, 2006, Folate intake and pancreatic cancer incidence: a prospective study of Swedish women and men, J. Natl. Cancer Inst, 98, 407, 10.1093/jnci/djj094 · DOI
- Gong, 2009, Intake of folate, vitamins B(6), B(12) and methionine and risk of pancreatic cancer in a large population-based case-control study, Cancer Causes Control, 20, 1317, 10.1007/s10552-009-9352-9 · DOI
- Giovannucci, 2009, Vitamin D and cancer incidence in the Harvard cohorts, Ann. Epidemiol, 19, 84, 10.1016/j.annepidem.2007.12.002 · DOI · Paper page
- Bao, 2010, Predicted vitamin D status and pancreatic cancer risk in two prospective cohort studies, Br. J. Cancer, 102, 1422, 10.1038/sj.bjc.6605658 · DOI
- Fink, 1983, Increased plasma pancreatic polypeptide in chronic alcohol abuse, Clin. Endocrinol. (Oxf), 18, 417, 10.1111/j.1365-2265.1983.tb00587.x · doi:10.1111/j.1365-2265.1983.tb00587.x
- Lieber, 1979, Alcohol related diseases and carcinogenesis, Cancer Res, 39, 2863
- Stewart, 2001, Alcoholic liver disease: new insight into mechanisms and preventive strategies, Trends Mol. Med, 7, 408, 10.1016/S1471-4914(01)02096-2 · DOI · Paper page
- Agarwal, 1997, Molecular genetic aspects of alcohol metabolism and alcoholism, Pharmacopsychiatry, 30, 79, 10.1055/s-2007-979487 · doi:10.1055/s-2007-979487
- Velema, 1986, Alcohol and pancreatic cancer insufficient epidemiologic evidence for a causal relationship, Epidemiol. Rev, 8, 28, 10.1093/oxfordjournals.epirev.a036294 · DOI
- Hassan, 2007, Risk factors for pancreatic cancer: case control study, Am. J. Gastroenterol, 102, 2696, 10.1111/j.1572-0241.2007.01510.x · DOI · Paper page
- Wang, 2016, Association between alcohol intake and the risk of pancreatic cancer: a dose–response meta-analysis of cohort studies, BMC Cancer, 16, 212, 10.1186/s12885-016-2241-1 · DOI · Paper page
- Lowenfels, 2004, Epidemiology and prevention of pancreatic cancer, Jpn J. Clin. Oncol, 34, 238, 10.1093/jjco/hyh045 · DOI
- Maisonneuve, 2005, Cigarette smoking accelerates progression of alcoholic chronic pancreatitis, Gut, 54, 510, 10.1136/gut.2004.039263 · DOI · Paper page
- Chuang, 2011, Exposure to environmental tobacco smoke in childhood and incidence of cancer in adulthood in never smokers in the European Prospective Investigation into Cancer and Nutrition, Cancer Causes Control, 22, 487, 10.1007/s10552-010-9723-2 · DOI
- Lowenfels, 2001, Cigarette smoking as a risk factor for pancreatic cancer in patients with hereditary pancreatitis, JAMA, 286, 169, 10.1001/jama.286.2.169 · DOI · Paper page
- El-Serag, 2009, Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: a population-based study of U.S. veterans, Hepatology, 49, 116, 10.1002/hep.22606 · DOI · Paper page
- Hassan, 2008, Association between hepatitis B virus and pancreatic cancer, J. Clin. Oncol, 26, 4557, 10.1200/JCO.2008.17.3526 · DOI · Paper page
- Risch, 2010, ABO blood group, Helicobacter pylori seropositivity, and risk of pancreatic cancer: a case-control study, J. Natl. Cancer Inst, 102, 502, 10.1093/jnci/djq007 · DOI · Paper page
- Kim, 2016, Risk factors associated with loco-regional failure after surgical resection in patients with resectablepancreatic cancer, PLoS ONE, 11, e0157196, 10.1371/journal.pone.0157196 · doi:10.1371/journal.pone.0157196
- Asiyanbola, 2009, Determining pattern of recurrence following pancreaticoduodenectomy and adjuvant 5-flurouracil-based chemoradiation therapy: effect of number of metastatic lymph nodes and lymph node ratio, J. Gastrointest. Surg, 13, 752, 10.1007/s11605-008-0762-x · DOI
- Das, 2015, Pancreatic cancer metastasis: are we being pre-EMTed?, Curr. Pharm. Des, 21, 1249, 10.2174/1381612821666141211115234 · DOI
- Turner, 2012, Epidemiology: allergy history, IgE, and cancer, Cancer Immunol. Immunother, 61, 1493, 10.1007/s00262-011-1180-6 · DOI
- Turner, 2006, An overview of the association between allergy and cancer, Int. J. Cancer, 118, 3124, 10.1002/ijc.21752 · DOI
- Gandini, 2005, Allergies and the risk of pancreatic cancer: a meta-analysis with review of epidemiology and biological mechanisms, Cancer Epidemiol. Biomarkers Prev, 14, 1908, 10.1158/1055-9965.EPI-05-0119 · DOI
- Anderson, 2009, Lifestyle, dietary, and medical history factors associated with pancreatic cancer risk in Ontario, Canada, Cancer Causes Control, 20, 825, 10.1007/s10552-009-9303-5 · doi:10.1007/s10552-009-9303-5
- Lo, 2007, Lifestyle, occupational, and reproductive factors in relation to pancreatic cancer risk, Pancreas, 35, 120, 10.1097/mpa.0b013e318053e7d3 · DOI
- Eppel, 2007, Allergies are associated with reduced pancreas cancer risk: a population-based casecontrol study in Ontario, Canada, Int. J. Cancer, 121, 2241, 10.1002/ijc.22884 · DOI
- Olson, 2012, Selected medical conditions and risk of pancreatic cancer, Mol. Carcinog, 51, 75, 10.1002/mc.20816 · DOI
- Gomez-Rubio, 2015, Reduced risk of pancreatic cancer associated with asthma and nasal allergies, Gut, 10.1136/gutjnl-2015-310442 · DOI
- Walker, 2015, Statin use and risk of pancreatic cancer: results from a large, clinic-based case-control study, Cancer, 121, 1287, 10.1002/cncr.29256 · DOI
- Jeon, 2015, The association of statin use after cancer diagnosis with survival in pancreatic cancer patients: a SEER-medicare analysis, PLoS ONE, 10
- Zhang, 2015, Aspirin might reduce the incidence of pancreatic cancer: a meta-analysis of observational studies, Sci. Rep, 5, 15460, 10.1038/srep15460 · DOI
- Larrson, 2006, Aspirin and nonsteroidal anti-inflammatory drug use and risk of pancreatic cancer: a meta-analysis, Cancer Epidemiol. Biomarkers Prev, 15, 2561, 10.1158/1055-9965.EPI-06-0574 · DOI
- Wang, 2007, PancPRO: risk assessment for individuals with a family history of pancreatic cancer, J. Clin. Oncol, 25, 1417, 10.1200/JCO.2006.09.2452 · DOI · Paper page
- Ojajärvi, 2007, Estimating the relative risk of pancreatic cancer associated with exposure agents in job title data in a hierarchical Bayesian meta-analysis, Scand. J. Work Environ. Health, 33, 325, 10.5271/sjweh.1153 · DOI
Cited by
Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors
Rawla, P., Sunkara, T., & Gaduputi, V. (2019) · World Journal of Oncology · doi:10.14740/wjon1166 · Cited by 2,269
Pancreatic Cancer: A Review of Risk Factors, Diagnosis, and Treatment
Zhao, Z., & Liu, W. (2020) · Technology in Cancer Research & Treatment · doi:10.1177/1533033820962117 · Cited by 348
Burden of Pancreatic Cancer: From Epidemiology to Practice
Khalaf, N., El-Serag, H. B., Abrams, H. R., & Thrift, A. P. (2021) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.02.054 · Cited by 308
Poh, A. R., & Ernst, M. (2021) · Cancers · doi:10.3390/cancers13122860 · Cited by 106
Park, B. K., Koh, H. D., Won, S. Y., Cho, Y. S., Seo, J. H., An, C., & Park, S. (2023) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo-22-863 · Cited by 10
Metadata
- Authors
- Midha, S., Chawla, S., & Garg, P. K.
- Venue
- Cancer Letters
- Publisher
- Elsevier BV
- Published
- 2016-10
- Volume
- 381
- Issue
- 1
- Pages
- 269-277
- ISSN
- 0304-3835 (ISSN-L)
- OpenAlex
- W2476900264
- Cited by
- 281
- References
- 5
- FWCI
- 6.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Modifiable and non-modifiable risk factors for pancreatic cancer: A review. https://app.cochat.ai/papers/10.1016/j.canlet.2016.07.022
- The paper
- Midha, S., Chawla, S., & Garg, P. K. (2016). Modifiable and non-modifiable risk factors for pancreatic cancer: A review. Cancer Letters. https://doi.org/10.1016/j.canlet.2016.07.022
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.